At a Glance
AI-generatedRaphael Pharmaceutical narrowed operating and net losses in FY2025 through moderated development investments, improving cash usage from operations while sustaining clinical advancement in cannabinoid therapies amid ongoing funding needs.
—
Market Cap
—
Revenue
—
Net Income
Fundamentals
How The Business Makes Money
Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops lead product candidate for the treatment of rheumatoid arthritis. It also intends to develop cannabinoid-based drug products for the treatment of oncology indications and other autoimmune diseases. The company is headquartered in Tel Aviv-Jaffa, Israel.
Industry Drug Manufacturers - Specialty & Generic
Activity
What Changed Recently
No significant events in the past 90 days.
Company Profile
CIK0001415397
ISINUS27785B2088
CUSIP27785B208
Phone972 5 2775 5072
Address4 Lui Paster, Jaffa, 6803605, IL
SEC EDGAR